MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling
Anthony Virtue(GlaxoSmithKline (United States)), Xiaofeng Yang(Temple College)
Cited by 70
Related Papers
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
|Journal of Hematology & Oncology|2013|797
Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation
|Arteriosclerosis Thrombosis and Vascular Biology|2016|217